Patent · US Active

Polymorph of a pharmaceutical

US7659405B2 · kind B2 · utility

4Cited by
8References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 21, 2006
Grant dateFeb 9, 2010
Priority date—
Expiry dateSep 21, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D277/28
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A new crystalline polymorph of ritonavir and methods for its use and preparation are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.